REVA PHARMA, is a fully integrated Healthcare and Pharmaceutical organization. Licensing, Product Development, Contract Manufacturing and Healthcare Services form the main activities of the company. Its operations and initiatives are backed up by regulatory approved infrastructure, which help to offer its partners, Products & Services complying with cGMP, GLP & EHS standards. It has carved out a name for itself in the Healthcare space across geographies for Reliability, Transparency and Trust.

Since incorporation in 2009, it has moved up in the industry ranking, with emphasis on its operations in Regulated, Expanding and Emerging markets. We have fulfilled our promise of providing value added products and services to our clients with rewarding partnerships.

National Healthcare Leadership Congress & Awards


Dr Gurpreet Sandhu, CEO and founder of Reva Pharma receiving Pharma Leadership Award endorsed by the World Federation of Healthcare Professionals on 28th September 2019 at the Taj Mahal Hotel, New Delhi.

OUR MISSION & VISION


"Our Mission is to provide Quality Pharmaceutical products and Healthcare services to our global business partners, ensuring highest standards in manufacturing and laboratory practices as well as compliance to Environment, Health and Safety norms. We are bound by our motto: Caring for Healthier Lives.

Our Vision is to be the permanent partner of choice for the products and services that we offer, by creating environment of Reliability, Transparency and Trust."

MARKETS


Our flagship markets are Japan, USA, Germany, Italy and Korea. We hold partnerships and alliances with Innovators, Biological, and Generic organizations the areas of Licensing, CRAM and API’s.

Research & Development

Research and Development is one of the major pillars on which a successful and customer oriented organization is built. We at Reva Pharma view R&D capabilities as a vital component of its ...

Regulatory Accreditations

REVA operates according to current Good Manufacturing and Laboratory Practice (cGMP and GLP). Our API and FDF manufacturing facilities have received regulatory approval from the following major health authorities.

OUR NEWS LETTERS


Reva Pharma Monthly Newsletters

RECENT NEWS


ALL NEWS

Chinese Scientists Believe New Drug Can Stop Covid-19 'W...

19 May 2020

A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to...

India's Jubilant Signs Licensing Deal For US Pharma Firm Gil...

13 May 2020

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selli...

Lockdown 3.0: Pharma Hubs Take Extra Precaution To Tame Covi...

09 May 2020

The country’s pharma plants have continued to run through the nationwide lockdown, and now a few cases of em...